PURA VIDA INVESTMENTS, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q2 2022$239,000
-63.4%
6,419
-66.3%
0.01%
-41.7%
Q4 2021$653,000
-64.8%
19,071
-61.9%
0.02%
-57.1%
Q3 2021$1,854,00050,0000.06%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$17,200,0009.25%
Velan Capital Investment Management LP 293,385$8,772,0008.14%
Paradigm Biocapital Advisors LP 499,190$14,926,0003.95%
TANG CAPITAL MANAGEMENT LLC 385,600$11,529,0002.31%
Rock Springs Capital Management LP 2,552,034$76,306,0001.92%
Samsara BioCapital, LLC 160,963$4,813,0001.21%
RTW INVESTMENTS, LP 1,859,471$55,598,0001.15%
Pier Capital, LLC 236,616$7,075,0000.90%
Avidity Partners Management LP 1,363,800$40,778,0000.85%
Rhenman & Partners Asset Management AB 170,472$5,097,0000.50%
View complete list of IMMUNOCORE HLDGS PLC shareholders